View Older Stories View More Recent Stories

May 29, 2025 07:49AM Bernstein on Intellia Therapeutics (NTLA): 'Investor Perception Takes Another Big Hit'

May 29, 2025 07:42AM Intellia Therapeutics (NTLA) discloses asymptomatic patient with grade 4 liver transaminase elevations

May 29, 2025 07:06AM Cantor Fitzgerald Reiterates Overweight Rating on Intellia Therapeutics (NTLA)

May 29, 2025 06:57AM H.C. Wainwright Reiterates Buy Rating on Intellia Therapeutics (NTLA)

May 29, 2025 05:34AM Intellia Therapeutics (NTLA) PT Lowered to $39 at BofA Securities

May 29, 2025 04:08AM Citizens JMP Reiterates Market Perform Rating on Intellia Therapeutics (NTLA)

May 12, 2025 07:12AM Intellia Therapeutics (NTLA) PT Lowered to $45 at Guggenheim

May 8, 2025 07:31AM Intellia Therapeutics (NTLA) Tops Q1 EPS by 17c

Apr 14, 2025 01:23PM NTLA DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important April 14 Deadline in Securities Class Action - NTLA

Apr 13, 2025 01:18PM NTLA DEADLINE TOMORROW: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important April 14 Deadline in Securities Class Action - NTLA

Apr 11, 2025 05:28PM NTLA DEADLINE MONDAY: ROSEN, A LEADING LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors with Losses in Excess of $50K to Secure Counsel Before Important April 14 Deadline in Securities Class

Apr 10, 2025 05:23PM NTLA DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important April 14 Deadline in Securities Class Action - NTLA

Apr 9, 2025 05:18PM NTLA DEADLINE: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important April 14 Deadline in Securities Class Action - NTLA

Apr 8, 2025 04:00PM NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Apr 7, 2025 07:49PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics

Apr 7, 2025 01:07PM NTLA IMPORTANT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important April 14 Deadline in Securities Class Action - NTLA

Apr 6, 2025 01:02PM NTLA IMPORTANT DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securit

Apr 5, 2025 12:48PM NTLA DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Intellia Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities C

Apr 4, 2025 12:39PM NTLA DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities

Apr 3, 2025 07:35AM Intellia Therapeutics (NTLA) Announces First Patient Dosed in the MAGNITUDE-2 Phase 3 Study of Nexiguran Ziclumeran

Apr 2, 2025 04:00PM NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Apr 2, 2025 03:47PM NTLA DEADLINE ALERT: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securit

Mar 31, 2025 07:36PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics

Mar 31, 2025 01:59PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 30, 2025 11:15AM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 28, 2025 02:36PM ROSEN, A LEADING LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 27, 2025 04:00PM NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 27, 2025 02:01PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 27, 2025 10:03AM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics

Mar 26, 2025 01:56PM ROSEN, A TOP RANKED LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 26, 2025 07:30AM Intellia Therapeutics (NTLA) Announces FDA RMAT Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Transthyretin ATTR

Mar 25, 2025 01:51PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 22, 2025 05:17PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 21, 2025 05:12PM ROSEN, A LEADING LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 21, 2025 04:00PM NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 20, 2025 05:07PM ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 18, 2025 06:14PM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics

Mar 17, 2025 06:36PM TOP RANKED ROSEN LAW FIRM Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 16, 2025 04:00PM NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 16, 2025 08:08AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics

Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma

Mar 15, 2025 08:30AM ROSEN, A LONGSTANDING LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 12, 2025 04:16PM Faruqi & Faruqi Reminds Intellia Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - NTLA

Mar 11, 2025 06:19PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 10, 2025 06:01PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 10, 2025 04:00PM NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 7, 2025 10:52PM ROSEN, A TOP-RANKED LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 6, 2025 04:45PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 4, 2025 08:06PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

Mar 4, 2025 04:00PM NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

View More Recent Stories View Older Stories